MAb for symptomatic COVID-19 in correctional facilities: an important opportunity

Lancet. 2021 Mar 6;397(10277):877-878. doi: 10.1016/S0140-6736(21)00354-8. Epub 2021 Feb 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • COVID-19 Drug Treatment*
  • Correctional Facilities*
  • Humans
  • Rhode Island
  • Risk Factors
  • SARS-CoV-2 / immunology

Substances

  • Antibodies, Monoclonal